Rare diseases
Investigational molecules
Locations
Gooimeer 2/35, 1411 DC Naarden, The Netherlands
Research activity is centered on Amyotrophic Lateral Sclerosis, with attention to the clinical course of progressive motor neuron degeneration, functional decline, and related neurological impairment.
Clinical interest is focused on disease progression in ALS and the therapeutic management of this rare and serious neurodegenerative disorder.
Prilenia Therapeutics B.V. runs clinical trials in conditions such as Amyotrophic lateral sclerosis, Huntington's disease, among others.
Clinical trials run by this sponsor – those enrolling participants first.
A study to evaluate the effectiveness and safety of pridopidine hydrochloride in patients with amyotrophic lateral sclerosis
BelgiumPhase 3 Study of Pridopidine Hydrochloride for Safety and Efficacy in Adults with Huntington’s Disease
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
